National Cancer Institute (NCI)
Toll-free phone lines and a website offering science-driven tools, information, and support have been effective in helping smokers quit. Many of the activities associated with the quitlines and the website are coordinated with the Centers for Disease Control and Prevention.
This section provides a selection of resources from NIH’s federal partners and is not intended to be a comprehensive list.
This website provides information from several federal partners about tobacco, its health effects, how to quit, and how to prevent children and young adults from picking up the habit. BeTobaccoFree.gov also has information about tobacco regulations and marketing policies; federal, state, and local laws; data and statistics; key reports; and tobacco-related clinical trials.
The Tobacco Control Working Group developed a strategic action plan committed to realizing the following vision: A society free of tobacco-related death and disease. This strategic action plan proposes a comprehensive approach designed to mobilize HHS’s expertise and resources in support of proven, pragmatic, achievable interventions that can be aggressively implemented not only at the federal level, but also within states and communities.
The Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) became law on June 22, 2009. It gives the Food and Drug Administration (FDA) the authority to regulate the manufacture, distribution, and marketing of tobacco products to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research, the Tobacco Regulatory Science Program (TRSP). The NIH has the infrastructure for the solicitation, review, and management of research, and several NIH Institutes and Centers have long supported tobacco-related research as part of their missions. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. NIH biomedical, behavioral, and social sciences research supported via funding from FDA will provide the scientific evidence needed to better inform FDA’s regulatory authorities.
The Centers for Disease Control and Prevention, through its Office on Smoking and Health, is the lead federal agency for comprehensive tobacco prevention and control. OSH is a division within the National Center for Chronic Disease Prevention and Health Promotion, which is located within CDC’s Coordinating Center for Health Promotion. Originally established in 1965 as the National Clearinghouse for Smoking and Health, OSH is dedicated to reducing the death and disease caused by tobacco use and exposure to secondhand smoke.
The USPSTF is an independent panel of non-federal experts in prevention and evidence-based medicine and is composed of primary care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, nurses, and health behavior specialists). The USPSTF conducts scientific evidence reviews of a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) and develops recommendations for primary care clinicians and health systems. The USPSTF recommends that clinicians ask all adults and pregnant women about tobacco use and provide interventions and counseling for those who use tobacco products.
The Guide to Community Preventive Services is a free resource with programs and policies to help improve health and prevent disease in communities across America. Systematic reviews are used to answer questions about which program and policy interventions have been proven effective; whether there are effective interventions; and the cost of effective interventions as well as the likely return on investment from these interventions. The Community Guide includes systematic reviews of several interventions, including provider-oriented interventions and interventions that restrict minors’ access to tobacco products.
Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy People has established benchmarks and monitored progress over time in order to: encourage collaborations across communities and sectors; empower individuals toward making informed health decisions; and measure the impact of prevention activities. Healthy People 2020 continues in this tradition with an ambitious, yet achievable, 10-year agenda to reduce illness, disability, and death related to tobacco use and secondhand smoke exposure.